Expertise in
1
conditions

Dr. Herbert L. Dupont

Infectious Disease
6720 Bertner St # 1-164, 
Houston, TX 
Expertise in
1
conditions
6720 Bertner St # 1-164, 
Houston, TX 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Herbert Dupont is an Infectious Disease provider in Houston, Texas. Dr. Dupont is highly rated in 1 condition, according to our data. His top areas of expertise are Viral Gastroenteritis, Liver Failure, Ebola Virus Disease, and Viral Hemorrhagic Fever.

His clinical research consists of co-authoring 136 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Infectious Disease
Licenses
Internal Medicine in TX
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Locations

6720 Bertner St # 1-164, Houston, TX 77030

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

Fresh, Frozen or Lyophilized Fecal Microbiota Transplantation for Multiple Recurrent C. Difficile Associated Diarrhea
Fresh, Frozen or Lyophilized Fecal Microbiota Transplantation for Multiple Recurrent C. Difficile Associated Diarrhea
Enrollment Status: Completed
Publish Date: May 23, 2024
Intervention Type: Biological
Study Phase: Phase 1/Phase 2
A Prospective, Randomized, Placebo-Controlled Pilot Study to Characterize the Intestinal Microbiome and to Evaluate the Safety and Fecal Microbiome Changes Following Twice Weekly Administration of Lyophilized PRIM-DJ2727 or Placebo Given Orally for 12 Weeks in Subjects With Parkinson's Disease
A Prospective, Randomized, Placebo-Controlled Pilot Study to Characterize the Intestinal Microbiome and to Evaluate the Safety and Fecal Microbiome Changes Following Twice Weekly Administration of Lyophilized PRIM-DJ2727 or Placebo Given Orally for 12 Weeks in Subjects With Parkinson's Disease
Enrollment Status: Completed
Publish Date: May 24, 2023
Intervention Type: Drug
Study Drug: PRIM-DJ2727 Filtered Fecal Microbiota
Study Phase: Phase 1
Phase II. Dose Ranging Study of the Safety and Efficacy of Orally Administered Lyophilized Fecal Microbiota Product (PRIM-DJ2727) for the Treatment of Recurrent Clostridium Difficile Infection (CDI)
Phase II. Dose Ranging Study of the Safety and Efficacy of Orally Administered Lyophilized Fecal Microbiota Product (PRIM-DJ2727) for the Treatment of Recurrent Clostridium Difficile Infection (CDI)
Enrollment Status: Terminated
Publish Date: March 06, 2020
Intervention Type: Biological
Study Phase: Phase 2
A Study of Fecal Microbiota Transplantation (FMT) for the Treatment of Recurrent C. Difficile Associated Diarrhea (RCDAD) Via Retention Enema or Oral Route
A Study of Fecal Microbiota Transplantation (FMT) for the Treatment of Recurrent C. Difficile Associated Diarrhea (RCDAD) Via Retention Enema or Oral Route
Enrollment Status: Completed
Publish Date: March 25, 2019
Intervention Type: Biological
Study Phase: Phase 1/Phase 2
A Prospective, Randomized Placebo Controlled Pilot Study to Characterize the Intestinal Microbiome and to Evaluate the Safety and Fecal Microbiome Changes Following Weekly Administration of Lyophilized PRIM-DJ2727 Given Orally in Subjects With Parkinson's Disease
A Prospective, Randomized Placebo Controlled Pilot Study to Characterize the Intestinal Microbiome and to Evaluate the Safety and Fecal Microbiome Changes Following Weekly Administration of Lyophilized PRIM-DJ2727 Given Orally in Subjects With Parkinson's Disease
Enrollment Status: Withdrawn
Publish Date: August 10, 2018
Intervention Type: Drug, Biological
Study Phase: Phase 1/Phase 2
Compassionate Use of Nitazoxanide for the Treatment of Clostridium Difficile Colitis in Patients Who Have Failed Conventional Therapy
Compassionate Use of Nitazoxanide for the Treatment of Clostridium Difficile Colitis in Patients Who Have Failed Conventional Therapy
Enrollment Status: Completed
Publish Date: December 15, 2017
Intervention Type: Drug
Study Phase: Phase 3
View 5 Less Clinical Trials

136 Total Publications

Re-visiting Bismuth Subsalicylate for the Prevention of Travelers Diarrhea.
Re-visiting Bismuth Subsalicylate for the Prevention of Travelers Diarrhea.
Journal: Journal of travel medicine
Published: June 09, 2025
Similar Doctors
Expertise in
14
conditions
Dr. Rodrigo R. Hasbun
Infectious Disease
Expertise in
14
conditions
Dr. Rodrigo R. Hasbun
Infectious Disease

UT Physicians

6410 Fannin St, 
Houston, TX 
 (0.5 miles away)
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients

Rodrigo Hasbun is an Infectious Disease provider in Houston, Texas. Dr. Hasbun is highly rated in 14 conditions, according to our data. His top areas of expertise are Meningitis, Bacterial Meningitis, Pneumococcal Meningitis, and Staphylococcal Meningitis. Dr. Hasbun is currently accepting new patients.

Expertise in
9
conditions
Dr. Rojelio Mejia
Infectious Disease
Expertise in
9
conditions
Dr. Rojelio Mejia
Infectious Disease

Baylor College Of Medicine

1502 Taub Loop, 
Houston, TX 
 (0.4 miles away)
713-873-4900
Languages Spoken:
English
See accepted insurances

Rojelio Mejia is an Infectious Disease provider in Houston, Texas. Dr. Mejia is highly rated in 9 conditions, according to our data. His top areas of expertise are Rhabditida Infections, Strongyloidiasis, Secernentea Infections, and Helminthiasis.

Harrys A. Torres
Expertise in
6
conditions
Dr. Harrys A. Torres
Infectious Disease
Expertise in
6
conditions
Dr. Harrys A. Torres
Infectious Disease

MD Anderson

2130 W Holcombe Blvd, Univ Of Tx M D Ande Life, 
Houston, TX 
 (0.4 miles away)
713-592-5433
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Harrys Torres is an Infectious Disease provider in Houston, Texas. Dr. Torres is highly rated in 6 conditions, according to our data. His top areas of expertise are Hepatitis C, Hepatitis, Hepatitis B, and Hepatitis E.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Dupont's expertise for a condition
ConditionClose
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile